<SEC-DOCUMENT>0001437749-17-018821.txt : 20171109
<SEC-HEADER>0001437749-17-018821.hdr.sgml : 20171109
<ACCEPTANCE-DATETIME>20171109130808
ACCESSION NUMBER:		0001437749-17-018821
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20171109
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20171109
DATE AS OF CHANGE:		20171109

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			GeoVax Labs, Inc.
		CENTRAL INDEX KEY:			0000832489
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
		IRS NUMBER:				870455038
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-52091
		FILM NUMBER:		171189882

	BUSINESS ADDRESS:	
		STREET 1:		1900 LAKE PARK DRIVE
		STREET 2:		SUITE 380
		CITY:			SMYRNA
		STATE:			2Q
		ZIP:			30080
		BUSINESS PHONE:		678-384-7220

	MAIL ADDRESS:	
		STREET 1:		1900 LAKE PARK DRIVE
		STREET 2:		SUITE 380
		CITY:			SMYRNA
		STATE:			2Q
		ZIP:			30080

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Geovax Labs, Inc.
		DATE OF NAME CHANGE:	20061002

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DAUPHIN TECHNOLOGY INC
		DATE OF NAME CHANGE:	19940826

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SUCCESSO INC
		DATE OF NAME CHANGE:	19910410
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>govx20171108_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<html>
<head>
	<title>govx20171108_8k.htm</title>
	<!-- Created by RDG HTML Converter v1.1.0.0 11/8/2017 4:42:34 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no"/>
</head>
<body style="font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 10px; margin-right: 10px; cursor: auto;">
<hr style="height: 3px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0">
<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 0 0 3pt 0">
<p>&nbsp;</p>

<p>&nbsp;
<p style="font-family:Times New Roman, Times, serif;font-size:18pt;margin:0pt;text-align:center;"><b>UNITED STATES</b></p>
</p>

<p style="font-family: Times New Roman,Times,serif; font-size: 18pt; margin: 0pt; text-align: center;"><b>SECURITIES AND EXCHANGE COMMISSION </b></p>

<p style="font-family: Times New Roman,Times,serif; font-size: 10pt; margin: 0pt; text-align: center;"><b>WASHINGTON, D.C. 20549&nbsp; </b></p>

<p style="font-family: Times New Roman,Times,serif; font-size: 10pt; margin: 0pt; text-align: center;"><b>&nbsp;</b></p>

<p style="margin: 0pt;">&nbsp;</p>

<hr style="text-align: center; height: 1px; color: #000000; background-color: #000000; width: 25%; border: none; margin: 3pt auto">
<p style="margin: 0pt;">&nbsp;</p>

<p style="font-family: Times New Roman,Times,serif; font-size: 18pt; margin: 0pt; text-align: center;"><b>FORM 8-K </b></p>

<p>&nbsp;
<p style="font-family: Times New Roman,Times,serif; font-size: 10pt; margin: 0pt; text-align: center;"><b>CURRENT REPORT </b></p>
</p>

<p style="font-family: Times New Roman,Times,serif; font-size: 10pt; margin: 0pt; text-align: center;"><b>Pursuant to Section 13 or 15(d) of the </b></p>

<p style="font-family: Times New Roman,Times,serif; font-size: 10pt; margin: 0pt; text-align: center;"><b>Securities Exchange Act of 1934 </b></p>

<p style="font-family: Times New Roman,Times,serif; font-size: 10pt; margin: 0pt; text-align: left;">&nbsp;</p>

<p style="font-family: Times New Roman,Times,serif; font-size: 10pt; margin: 0pt; text-align: center;"><b>Date of report (Date of earl</b><font style="font-family:Times New Roman, Times, serif;font-size:10pt;"><b>i</b><b>est event reported): </b><b> </b><b>November</b><b> </b><b>9</b><b>,</b><b> 20</b><b>1</b><b>7</b></font></p>

<p style="font-family: Times New Roman,Times,serif; font-size: 10pt; margin: 0pt; text-align: center;">&nbsp;</p>

<hr style="text-align: center; height: 1px; color: #000000; background-color: #000000; width: 25%; border: none; margin: 3pt auto">
<p style="margin: 0pt;">&nbsp;</p>

<p style="font-family: Times New Roman,Times,serif; font-size: 18pt; margin: 0pt; text-align: center;"><b>GEOVAX LABS, INC.</b></p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>(Exact name of registrant as specified in </b><font style="font-family:Times New Roman, Times, serif;font-size:10pt;"><b>its c</b><b>harter) </b></font></p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;">&nbsp;</p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" id="TBL1" style="width:100%;text-indent:0;font-family:Times New Roman, Times, serif;font-size:10pt;">

		<tr>
			<td style="vertical-align:top;width:31.3%;">
			<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>Delaware</b></p>
			</td>
			<td style="vertical-align:bottom;width:3%;">
			<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:31.3%;">
			<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>000-52091</b></p>
			</td>
			<td style="vertical-align:bottom;width:3%;">
			<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:31.3%;">
			<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>87-0455038</b></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:31.3%;">
			<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>(State or other jurisdiction of</b></p>

			<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>incorporation or organization)</b></p>
			</td>
			<td style="vertical-align:bottom;width:3%;">
			<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:31.3%;">
			<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>(Commission File No.)</b></p>
			</td>
			<td style="vertical-align:bottom;width:3%;">
			<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:31.3%;">
			<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>(IRS Employee Identification No.)</b></p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>&nbsp;</b></p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>1900 Lake Park Drive</b><font style="font-family:Times New Roman, Times, serif;font-size:10pt;"><b>, </b><b>Suite 380</b></font></p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>Smyrna, Georgia 30080</b></p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>(Address of </b><font style="font-family:Times New Roman, Times, serif;font-size:10pt;"><b>p</b><b>rincipal </b><b>e</b><b>xecutive </b><b>o</b><b>ffices)</b><b> (Z</b><b>ip code)</b></font></p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>(678) 384-7220</b></p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>(</b><font style="font-family:Times New Roman, Times, serif;font-size:10pt;"><b>Registrant&rsquo;s t</b><b>elephone number</b><b>, including area code</b><b>) </b></font></p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under <font style="font-family:Times New Roman, Times, serif;font-size:10pt;">any of the following provisions.</font></p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)<font style="font-family:Times New Roman, Times, serif;font-size:10pt;">.</font></p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR240.14a-12)<font style="font-family:Times New Roman, Times, serif;font-size:10pt;">.</font></p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)<font style="font-family:Times New Roman, Times, serif;font-size:10pt;">).</font></p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">[ ] Pre-commencement communications pursuant to<font style="font-family:Times New Roman, Times, serif;font-size:10pt;"> Rule 13e-4(c) under the Exchange Act (17 CAR 240.13(e)-4(c)).</font></p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule<font style="font-family:Times New Roman, Times, serif;font-size:10pt;">&nbsp;405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.</font></p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Emerging growth company.<font style="font-family:Times New Roman, Times, serif;font-size:10pt;">&nbsp;&nbsp;&nbsp;&#9744;</font></p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended<font style="font-family:Times New Roman, Times, serif;font-size:10pt;"> transition period for complying with any new or revised financial accounting standards provided pursuant to Section&nbsp;13(a) of the Exchange Act. &#9744;</font></p>

<p style="font-family: Times New Roman,Times,serif; font-size: 10pt; margin: 0pt; text-align: left;">&nbsp;</p>

<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0">
<hr style="height: 3px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 0 0 3pt 0">
<p style="margin: 0pt;">&nbsp;</p>

<div id="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div id="PGNUM" style="text-align: center; width: 100%">&nbsp;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div id="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">This Form 8-K and other reports fi<font style="font-family:Times New Roman, Times, serif;font-size:10pt;">led by GeoVax Labs, Inc. (the &ldquo;Registrant&rdquo;) from time to time with the Securities and Exchange Commission (collectively the &ldquo;Filings&rdquo;) contain forward looking statements and information that are based upon beliefs of, and information currently available to, the Registrant&#39;s management as well as estimates and assumptions made by the Registrant&rsquo;s management. When used in the Filings the words &ldquo;anticipate&rdquo;, &ldquo;believe&rdquo;, &ldquo;estimate&rdquo;, &ldquo;expect&rdquo;, &ldquo;future&rdquo;, &ldquo;intend&rdquo;, &ldquo;plan&rdquo; or the negative of these terms and similar expressions as they relate to the Registrant or the Registrant&rsquo;s management identify forward looking statements. Such statements reflect the current view of the Registrant with respect to future events and are subject to risks, uncertainties, assumptions and other factors relating to the Registrant&rsquo;s industry, operations and results of operations and any businesses that may be acquired by the Registrant. Should one or more of these risks or uncertainties materialize, or should the underlying assumptions prove incorrect, actual results may differ significantly from those anticipated, believed, estimated, expected, intended or planned.</font></p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><b>&nbsp;</b></p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><b>Item 2.02<font style="font-family:Times New Roman, Times, serif;font-size:10pt;">&nbsp;&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Results of Operations and Financial Condition</font></b></p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:72pt;">On <font style="font-family:Times New Roman, Times, serif;font-size:10pt;">November 9, 2017 we issued a press release reporting our results of operations for the quarter ended September 30, 2017. A copy of the press release is attached to this Current Report.</font></p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><b>Item 9.01<font style="font-family:Times New Roman, Times, serif;font-size:10pt;">&nbsp;&nbsp;&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Financial Statements and Exhibits</font></b></p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:72pt;"><a href="ex_99917.htm" style="-sec-extract:exhibit;"><font style="font-family:Times New Roman, Times, serif;font-size:10pt;">Exhibit 99.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Press Release</font></a></p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:63pt;margin-right:0pt;margin-top:0pt;text-align:left;text-indent:-63pt;">&nbsp;</p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><b>&nbsp;</b></p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><b>&nbsp;</b></p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>SIGNATURE</b></p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Current Report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Dated: <font style="font-family:Times New Roman, Times, serif;font-size:10pt;">November 9, 2017</font></p>

<table border="0" cellpadding="0" cellspacing="0" style="text-indent: 0; width: 100%;FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">

		<tr>
			<td valign="top" width="50%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&nbsp;</font></p>
			</td>
			<td colspan="2" valign="top" width="38%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family:Times New Roman, Times, serif; font-size:10pt">GEOVAX LABS, INC.</font></p>
			</td>
			<td valign="top" width="12%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td valign="top" width="50%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="3%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="35%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="12%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td valign="top" width="50%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="3%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&nbsp;</font></p>
			</td>
			<td align="left" nowrap="nowrap" valign="bottom" width="35%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="12%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td align="left" style="text-align: left;" valign="top" width="50%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&nbsp;</font></p>
			</td>
			<td style="text-align: left" valign="top" width="3%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">By: </font></p>
			</td>
			<td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="top" width="35%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">/s/&nbsp;</font><font style="font-family:Times New Roman, Times, serif; font-size:10pt">Mark W. Reynolds</font></p>
			</td>
			<td valign="top" width="12%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td valign="top" width="50%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="3%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="35%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family:Times New Roman, Times, serif; font-size:10pt">Mark W. Reynolds</font></p>
			</td>
			<td valign="top" width="12%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td valign="top" width="50%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="3%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="35%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family:Times New Roman, Times, serif; font-size:10pt">Chief Financial Officer</font></p>
			</td>
			<td valign="top" width="12%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&nbsp;</font></p>
			</td>
		</tr>

</table>

<p>&nbsp;
<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>
</p>

<p style="font-family: Times New Roman,Times,serif; font-size: 10pt; margin: 0pt; text-align: center;">2</p>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex_99917.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
<head>
	<title>ex_99917.htm</title>
	<!-- Created by RDG HTML Converter v1.1.0.0 11/8/2017 4:37:21 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no"/>
</head>
<body style="font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 10px; margin-right: 10px; cursor: auto;">
<p style="margin-bottom: 0px; text-align: right; margin-top: 0px"><font style="font-size: 10pt; font-family: Times New Roman, Times, serif"><b>Exhibit 99.1</b></font></p>

<p style="margin-bottom: 0px; text-align: left; margin-top: 0px"><font style="font-size: 10pt; font-family: Times New Roman, Times, serif">&nbsp;</font></p>

<p style="font-family: Times New Roman,Times,serif; font-size: 12pt; margin: 0pt;"><img src="geologo.jpg"></p>

<p style="font-family: Times New Roman,Times,serif; font-size: 12pt; margin: 0pt;"><b>&nbsp;</b></p>

<p style="font-family:Times New Roman, Times, serif;font-size:12pt;margin:0pt;text-align:center;"><b>GeoVax </b><font style="font-family:Times New Roman, Times, serif;font-size:12pt;"><b>Reports</b><b> </b><b>2017</b><b> </b><b>Third</b><b> Quarter Financial Results</b></font></p>

<p style="font-family:Times New Roman, Times, serif;font-size:12pt;margin:0pt;text-align:center;"><b>a</b><font style="font-family:Times New Roman, Times, serif;font-size:12pt;"><b>nd </b><b>Development Program</b><b> Update</b><b>s</b></font></p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><i>&nbsp;</i></p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><i>Progress in Multiple Vaccine Programs Including</i></p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><i>HIV</i><font style="font-family:Times New Roman, Times, serif;font-size:10pt;"><i>,</i><i> Zika,</i><i> Lassa Fever</i><i>, Malaria, Hepatitis B, </i><i>and Cancer</i><i> Immunotherapy</i></font></p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><i>&nbsp;</i></p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><b>ATLANTA, G</b><font style="font-family:Times New Roman, Times, serif;font-size:10pt;"><b>A</b><b>, </b><b>November</b><b> </b><b>9</b><b>, 2017</b><b> </b>&ndash; GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines using its novel viral vector platform technology, announced its financial results for the quarter ended September 30, 2017, and provided the following update for its research and development programs.</font></p>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><b>Vaccine Development Update</b><font style="font-family:Times New Roman, Times, serif;font-size:10pt;"><b>:</b></font></p>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><i><b>Continued Validation of MVA-VLP Vaccine Platform <font style="font-family:Times New Roman, Times, serif;font-size:10pt;">&ndash; </font></b></i><font style="font-family:Times New Roman, Times, serif;font-size:10pt;">GeoVax&rsquo;s product pipeline is based on its Modified Vaccine Ankara (MVA) Virus-Like Particle (VLP) vaccine platform. This platform supports <i>in vivo</i> production of non-infectious VLPs from the cells of the very person receiving the vaccine, mimicking a natural infection and stimulating both the humoral and cellular arms of the immune system to recognize, prevent, and control target infections.</font></p>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;">As discussed in more detail below, the Company<font style="font-family:Times New Roman, Times, serif;font-size:10pt;">&rsquo;s original application of its technology was in developing preventive HIV vaccines. More recently it expanded to preventive vaccines for Zika Virus, hemorrhagic fever viruses (Ebola, Sudan, Marburg, and Lassa), and malaria, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections and cancers. </font></p>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;">GeoVax continues to build an impressive data set for its MVA-VLP platform, now with preclinical proof-of-concept in four disease indications (HIV, Zika, Lassa, Ebola), and excellent safety and immunogenicity in clinical trials of its HIV vaccine involving 500 individuals. These data provide strong rationale for expecting clinical efficacy for <font style="font-family:Times New Roman, Times, serif;font-size:10pt;">the current vaccine development programs, as well as encouragement for future pipeline expansion to additional disease indications.</font></p>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><i><b>HIV Preventive Vaccine</b></i><font style="font-family:Times New Roman, Times, serif;font-size:10pt;"><i><b>s</b></i><i><b> &ndash; </b></i>GeoVax&rsquo;s most advanced program is a prophylactic vaccine (designated GOVX-B11) for the clade B subtype of HIV, the most common form of HIV in North America, Western Europe, Australia and Japan. This program has successfully completed phase 1 and phase 2a human clinical trials, which were conducted by the HIV Vaccine Trials Network (HVTN) with funding from the National Institute of Allergy and Infectious Diseases (NIAID). </font></p>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;">In January 2017, the HVTN initiated a phase 1 human clinical trial of GOVX-B11, <font style="font-family:Times New Roman, Times, serif;font-size:10pt;">(trial designation HVTN&nbsp;114) to evaluate the durability of immune responses elicited by GOVX-B11 and the effects of late boosts (additional vaccinations) on the antibody responses elicited by the GOVX-B11.</font></p>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The next <font style="font-family:Times New Roman, Times, serif;font-size:10pt;">planned clinical trial of GOVX-B11 will be an additional Phase 1 trial, evaluating the safety and immunogenicity of a prime-boost regimen of GOVX-B11 with and without two additional protein boosts. This trial will be conducted by HVTN with funding from NIAID; the Company anticipates a start date in mid-2018. Both this trial and HVTN 114 will contribute data critical in determining the regimen to be used in a future phase 2b efficacy trial. During 2017, GeoVax continued its work under a NIAID contract of up to $7.8 million for production of the DNA component of GOVX-B11 intended for the later-stage clinical trials. </font></p>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;">GeoVax<font style="font-family:Times New Roman, Times, serif;font-size:10pt;"> also continued preclinical work funded by grants from NIAID for its vaccine for the clade C HIV subtype prevalent in Africa. In October 2017, the Company reported the elicitation of a key precursor for broadly neutralizing antibody for the HIV CD4 binding site, a significant advance in HIV vaccine development. The findings were published in the peer-reviewed open access journal <i>PLOS ONE,</i><i> </i>and can be viewed at</font><font style="font-family:Times New Roman, Times, serif;font-size:10pt;">: </font><font style="font-family:Times New Roman, Times, serif;font-size:10pt;"><u>http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0177863</u></font><font style="font-family:Times New Roman, Times, serif;font-size:10pt;">.</font></p>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><i><b>HIV Therapeutic </b></i><font style="font-family:Times New Roman, Times, serif;font-size:10pt;"><i><b>Vaccine</b></i><i><b> (&ldquo;Functional Cure&rdquo; Program)</b></i><b> &ndash; </b>In March 2017, GeoVax began a collaboration with American Gene Technologies International, Inc. (AGT) with the goal of developing a functional cure for HIV infection through AGT&rsquo;s gene therapy technology in combination with GeoVax&rsquo;s HIV vaccine. The Company expects AGT to file an Investigation New Drug (IND) application in early 2018 and to initiate human clinical trials of the companies&rsquo; combined technologies in mid-2018.</font></p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><b>MORE</b></p>

<div id="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div id="PGNUM" style="text-align: center; width: 100%">&nbsp;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div id="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><i><b>Zika Vaccine</b></i><font style="font-family:Times New Roman, Times, serif;font-size:10pt;"> &ndash; In June 2017, at the American Society for Microbiology (ASM) conference (ASM MICROBE 2017), and later in August at the 5<sup>th</sup> Annual Meeting of Cambridge Healthtech Institute, Immuno-Oncology Summit, in Boston, as well as</font><font style="font-family:Times New Roman, Times, serif;font-size:10pt;"> in October 2017, at the 18<sup>th</sup> World Vaccine Congress Europe in Barcelona,</font><font style="font-family:Times New Roman, Times, serif;font-size:10pt;"><b> </b></font><font style="font-family:Times New Roman, Times, serif;font-size:10pt;">GeoVax presented data showing that a single dose of its Zika vaccine (GEO-ZM02) gave 100% protection in mice challenged with a lethal dose of Zika virus (ZIKV) delivered directly into the brain</font><font style="font-family:Times New Roman, Times, serif;font-size:10pt;">. This is the first report of i) a Zika vaccine based on the ZIKV non-structural (NS1) protein, and ii) single-dose protection against ZIKV using an immunocompetent lethal mouse challenge model. The vaccine was tested at the Centers for Disease Control and Prevention (CDC) in Ft. Collins, CO with funding from the CDC. GeoVax&rsquo;s approach to a Zika vaccine is unique in that it uses the non-structural protein NS1instead of the commonly used structural proteins for immunogens, and thus avoids potential Antibody Dependent Enhancement (ADE) of infection, a safety concern for Zika vaccines based on structural proteins.</font></p>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Preclinical efficacy of GEO-ZM02 <font style="font-family:Times New Roman, Times, serif;font-size:10pt;">was published in the peer-reviewed open access journal Scientific Reports by Nature Research under the title of &ldquo;<i>A Zika Vaccine Targeting NS1 Protein Protects Immunocompetent Adult Mice in a Lethal</i><i> Challenge Model</i><i>&rdquo;</i> and can be viewed at www.nature.com/articles/s41598-017-15039-8.</font></p>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Also in June, the National Institutes of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), awarded GeoVax a Small Business Innovative Research (SBIR) grant of <font style="font-family:Times New Roman, Times, serif;font-size:10pt;">$600,000 to support advanced preclinical testing, including non-human primate studies, for its Zika vaccine development program in preparation for a Phase 1 human clinical study.</font></p>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><i><b>Lassa Fever Vaccine</b></i><font style="font-family:Times New Roman, Times, serif;font-size:10pt;"> &ndash; In July 2017, GeoVax reported a significant step forward in the development of a vaccine candidate for protection against Lassa hemorrhagic fever virus (LASV). Efficacy testing in a murine challenge model (using a chimeric LASV reassortant) showed a single intramuscular dose of GEO-LM01, provided 100% protection to mice infected with a lethal dose of the challenge virus directly delivered into the brain. The study was conducted, and successfully repeated, at the Institute of Human Virology at the University of Maryland School of Medicine. Also in July, the Company expanded its LASV vaccine development efforts through a collaboration with The Scripps Research Institute located in San Diego, CA.</font></p>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family: Times New Roman,Times,serif; font-size: 10pt; margin: 0pt; text-align: justify;">I<font style="font-family:Times New Roman, Times, serif;font-size:10pt;">n October, at the International Society for Vaccines, at the Institute Pasteur Paris, France, GeoVax presented updates on efficacy data of its single dose vaccine for Lassa fever virus. </font></p>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Earlier<font style="font-family:Times New Roman, Times, serif;font-size:10pt;">, a single dose of GeoVax&rsquo;s Ebola (EBOV) vaccine was shown to protect 100% of rhesus monkeys against death. GeoVax is also developing vaccines against Sudan virus (SUDV) and Marburg virus (MARV), two other lethal hemorrhagic fever viruses for which no effective vaccine currently exists. In addition to developing the four individual hemorrhagic fever vaccines (EBOV, LASV, SUDV, MARV), the Company&rsquo;s goal is to combine the vaccines into a single tetravalent vaccine to provide broad protection for individuals at-risk for these viruses. In October, together with its collaborators at Rocky Mountain Laboratories of NIH, GeoVax submitted a manuscript for publication to a prestigious peer reviewed Journal describing efficacy data for its MVA-VLP-Ebola vaccine.</font></p>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><i><b>Immuno-oncology Program</b></i><font style="font-family:Times New Roman, Times, serif;font-size:10pt;"> &ndash; In August 2017, at the 5<sup>th</sup> Annual Meeting of Cambridge Healthtech Institute, Immuno-Oncology Summit, in Boston, MA,</font><font style="font-family:Times New Roman, Times, serif;font-size:10pt;"> as well as in October, at the 18<sup>th</sup> World Vaccine Congress Europe in Barcelona, GeoVax presented preliminary results from studies of its cancer vaccine in collaboration with ViaMune, Inc. The studies were performed by the laboratory of Dr. Pinku Mukherjee, PhD, at the University of North Carolina at Charlotte.</font><font style="font-family:Times New Roman, Times, serif;font-size:10pt;"> </font><font style="font-family:Times New Roman, Times, serif;font-size:10pt;">GeoVax and ViaMune are each developing products that target an abnormal form of the cell surface-associated protein, Mucin 1 (MUC1), which is overexpressed in metastatic cancers (e.g. breast, pancreatic, lung, and ovarian cancers) and circulating tumor cells and which is often used as a diagnostic marker for cancer progression. In a human MUC1 colon adenocarcinoma mouse tumor model, groups of hMUC1 transgenic mice with established tumors were treated with MTI (ViaMune&rsquo;s synthetic vaccine), MVA-VLP-MUC1 (GeoVax&rsquo;s viral-vectored vaccine) or a combination of both. All treatment groups received an immune checkpoint inhibitor in the form of an anti-PD-1 antibody. The results from two studies indicate that a combined vaccine approach increases the therapeutic potential of anti-PD-1 therapy, giving excellent scientific justification to vigorously pursue additional investigation of this potential cancer vaccine. </font></p>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><b>MORE</b></p>

<div id="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div id="PGNUM" style="text-align: center; width: 100%">&nbsp;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div id="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><i><b>Malaria Vaccine</b></i><font style="font-family:Times New Roman, Times, serif;font-size:10pt;"> &ndash; In January, GeoVax initiated a program to develop a malaria vaccine using its MVA-VLP viral vector platform through collaboration with The Burnet Institute in Australia. The Company has completed construction of 4 vaccine candidates which have been shipped to Burnet Institute and are currently being evaluated in preclinical proof-of-concept studies.</font></p>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><i><b>Chronic Hepatitis B </b></i><font style="font-family:Times New Roman, Times, serif;font-size:10pt;"><i><b>Immunotherapy</b></i><b> &ndash;</b> During the first quarter of 2017, GeoVax added Georgia State University and Peking University as collaborators to develop a therapeutic vaccine for chronic hepatitis B infection. Preclinical proof-of-concept studies are ongoing.</font></p>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><b>Financial Review</b></p>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;">GeoVax reported a net loss of $<font style="font-family:Times New Roman, Times, serif;font-size:10pt;">588,787 ($0.01 per share) for the three months ended September 30, 2017, compared to $464,200 ($0.01 per share) for the same period in 2016. For the nine months ended September 30, 2017, the Company&rsquo;s net loss was $1,653,979 ($0.03 per share) as compared to $2,336,314 ($0.06 per share) in 2016. </font></p>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The Company reported <font style="font-family:Times New Roman, Times, serif;font-size:10pt;">grant and collaboration revenues of $247,997 and $895,866 for the three-month and nine-month periods of 2017, respectively. This compares to $440,106 and $653,986 of grant revenue reported for the comparable periods of 2016. As of September 30, 2017, there is $744,769 in approved grant funds remaining and available for use.</font></p>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Research and development (R&amp;D) expenses were $<font style="font-family:Times New Roman, Times, serif;font-size:10pt;">498,200 and $1,568,093 for the three-month and nine- month periods of 2017, respectively, as compared to $683,939 and $1,519,519 for the comparable periods of 2016. R&amp;D expenses include direct costs funded by NIH grants, as well as other vaccine manufacturing and testing costs. General and administrative (G&amp;A) expenses were $340,143 and $985,001 for the three-month and nine-month periods of 2017, respectively, as compared to $220,707 and $1,472,030 for the comparable periods of 2016.</font></p>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;">GeoVax reported cash balances of $<font style="font-family:Times New Roman, Times, serif;font-size:10pt;">343,826 at September 30, 2017, as compared to $454,030 at December 31, 2016. Summarized financial information is attached. Further information concerning the Company&rsquo;s financial position and results of operations are included in its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission.</font></p>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="background-color:#FFFFFF;font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><b>About GeoVax</b></p>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="background-color:#FFFFFF;font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;">GeoVax Labs, Inc., is a clinical-stage biotechnology company developing human vaccines against infectious diseases using its MVA-VLP vaccine platform. The Company<font style="font-family:Times New Roman, Times, serif;font-size:10pt;">&rsquo;s HIV-1 preventive vaccine for the clade B, the dominant subtype in the Americas, Western Europe and Australia, is advancing in human trials conducted by the HIV Vaccine Trials Network (HVTN). Preclinical programs are focused on preventive vaccines for Zika Virus, hemorrhagic fever viruses (Ebola, Sudan, Marburg, and Lassa), and malaria, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections and cancers. GeoVax&rsquo;s vaccine platform supports <i>in vivo</i> production of non-infectious VLPs from the cells of the very person receiving the vaccine, mimicking a natural infection and stimulating both the humoral and cellular arms of the immune system to recognize, prevent, and control the target infection. For more information, visit</font><font style="font-family:Times New Roman, Times, serif;font-size:10pt;"> www.geovax.com.</font></p>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><i><b>Forward-Looking Statements</b></i></p>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="background-color:#FFFFFF;font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><i>Certain statements in this document are &quot;forward-looking statements&quot; within the meaning of the Private Securities Litigation Reform Act. These statements are based on management&#39;s current expectations and are subject to uncertainty and changes in circumstances. Actual results may differ materially from those included in these statements due to a variety of factors, including whether: GeoVax can develop and manufacture its vaccines with the desired characteristics in a timely manner, GeoVax&#39;s vaccines will be safe for human use, GeoVax&#39;s vaccines will effectively prevent targeted infections in humans, GeoVax<font style="font-family:Times New Roman, Times, serif;font-size:10pt;">&rsquo;s vaccines will receive regulatory approvals necessary to be licensed and marketed, GeoVax raises required capital to complete vaccine development, there is development of competitive products that may be more effective or easier to use than GeoVax&#39;s products, GeoVax will be able to enter into favorable manufacturing and distribution agreements, and other factors, over which GeoVax has no control. GeoVax assumes no obligation to update these forward-looking statements, and does not intend to do so. More information about these factors is contained in GeoVax&#39;s filings with the Securities and Exchange Commission including those set forth at &quot;Risk Factors&quot; in GeoVax&#39;s Form 10-K</font></i><font style="font-family:Times New Roman, Times, serif;font-size:10pt;"><i>.</i></font></p>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><b>Contact: </b></p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Robert T. McNally, Ph.D.</p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;">GeoVax Labs, Inc.</p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;">investor@geovax.com</p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;">678-384-7220</p>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>&nbsp;</b></p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>FINANCIAL TABLES FOLLOW</b></p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<div id="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div id="PGNUM" style="text-align: center; width: 100%">&nbsp;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div id="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" id="TBL1" style="width:100%;text-indent:0;font-family:Times New Roman, Times, serif;font-size:10pt;">

		<tr>
			<td colspan="1" style="vertical-align:top;width:100%;">
			<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>GEOVAX LABS, INC.</b></p>
			</td>
		</tr>
		<tr>
			<td colspan="1" style="vertical-align:top;width:100%;">
			<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>Condensed Consolidated Statements of Operations Information</b></p>
			</td>
		</tr>
		<tr>
			<td colspan="1" style="vertical-align:top;width:100%;">
			<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>(amounts in thousands, except per share data)</b></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:2.4%;">&nbsp;</td>
		</tr>

</table>

<p style="margin: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman,Times,serif; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.D3" style="font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td colspan="6" id=".amt.D3" style="text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-align:center;">Three Months Ended</p>
			</td>
			<td id=".trail.D3" style="font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.D5" style="font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td colspan="6" id=".amt.D5" style="text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;">Nine<font style="font-family:Times New Roman, Times, serif;font-size:10pt;"> Months Ended</font></p>
			</td>
			<td id=".trail.D5" style="font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.D3" style="font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td colspan="6" id=".amt.D3" style="text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;">September<font style="font-family:Times New Roman, Times, serif;font-size:10pt;"> 30,</font></p>
			</td>
			<td id=".trail.D3" style="font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".lead.D5" style="font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td colspan="6" id=".amt.D5" style="text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;">September<font style="font-family:Times New Roman, Times, serif;font-size:10pt;"> 30, </font></p>
			</td>
			<td id=".trail.D5" style="font-family: Times New Roman,Times,serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.D2" style="font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td colspan="2" id=".amt.D2" style="text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;">201<font style="font-family:Times New Roman, Times, serif;font-size:10pt;">7</font></p>
			</td>
			<td id=".trail.D2" style="font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".lead.D3" style="font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td colspan="2" id=".amt.D3" style="text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;">20<font style="font-family:Times New Roman, Times, serif;font-size:10pt;">16</font></p>
			</td>
			<td id=".trail.D3" style="font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".lead.D4" style="font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td colspan="2" id=".amt.D4" style="text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;">201<font style="font-family:Times New Roman, Times, serif;font-size:10pt;">7</font></p>
			</td>
			<td id=".trail.D4" style="font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".lead.D5" style="font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td colspan="2" id=".amt.D5" style="text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;">20<font style="font-family:Times New Roman, Times, serif;font-size:10pt;">16</font></p>
			</td>
			<td id=".trail.D5" style="font-family: Times New Roman,Times,serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: Times New Roman,Times,serif; font-size: 10pt; width: 52%;">
			<p style="font-family: Times New Roman,Times,serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Revenues</p>
			</td>
			<td id=".lead.B2" style="font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B2" style="font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B2" style="text-align: left; font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B2" style="font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.B3" style="font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B3" style="font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B3" style="text-align: left; font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B3" style="font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.B4" style="font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B4" style="font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B4" style="text-align: left; font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B4" style="font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.B5" style="font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B5" style="font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B5" style="text-align: left; font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B5" style="font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: Times New Roman,Times,serif; font-size: 10pt;">
			<p style="font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Grant r<font style="font-family:Times New Roman, Times, serif;font-size:10pt;">evenue</font></p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.2" style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">248</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.3" style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">440</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.4" style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">896</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.5" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.5" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.5" style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">654</td>
			<td id=".trail.5" nowrap="true" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td>&nbsp;</td>
			<td id=".lead.B2">&nbsp;</td>
			<td id=".symb.B2">&nbsp;</td>
			<td id=".amt.B2">&nbsp;</td>
			<td id=".trail.B2">&nbsp;</td>
			<td id=".lead.B3">&nbsp;</td>
			<td id=".symb.B3">&nbsp;</td>
			<td id=".amt.B3">&nbsp;</td>
			<td id=".trail.B3">&nbsp;</td>
			<td id=".lead.B4">&nbsp;</td>
			<td id=".symb.B4">&nbsp;</td>
			<td id=".amt.B4">&nbsp;</td>
			<td id=".trail.B4">&nbsp;</td>
			<td id=".lead.B5">&nbsp;</td>
			<td id=".symb.B5">&nbsp;</td>
			<td id=".amt.B5">&nbsp;</td>
			<td id=".trail.B5">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: Times New Roman,Times,serif; font-size: 10pt;">
			<p style="font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Operating expenses:</p>
			</td>
			<td id=".lead.B2" style="font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B2" style="font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B2" style="text-align: left; font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B2" style="font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.B3" style="font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B3" style="font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B3" style="text-align: left; font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B3" style="font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.B4" style="font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B4" style="font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B4" style="text-align: left; font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B4" style="font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.B5" style="font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B5" style="font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B5" style="text-align: left; font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B5" style="font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: Times New Roman,Times,serif; font-size: 10pt;">
			<p style="font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Research and development</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">498</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">684</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.4" style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">1,568</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.5" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.5" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.5" style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">1,519</td>
			<td id=".trail.5" nowrap="true" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: Times New Roman,Times,serif; font-size: 10pt;">
			<p style="font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">General and administrative</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.2" style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">340</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.3" style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">221</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.4" style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">985</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.5" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.5" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.5" style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">1,472</td>
			<td id=".trail.5" nowrap="true" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.2" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.2" style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">838</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.3" style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">905</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.4" style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">2,553</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.5" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.5" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.5" style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">2,991</td>
			<td id=".trail.5" nowrap="true" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td>&nbsp;</td>
			<td id=".lead.B2">&nbsp;</td>
			<td id=".symb.B2">&nbsp;</td>
			<td id=".amt.B2">&nbsp;</td>
			<td id=".trail.B2">&nbsp;</td>
			<td id=".lead.B3">&nbsp;</td>
			<td id=".symb.B3">&nbsp;</td>
			<td id=".amt.B3">&nbsp;</td>
			<td id=".trail.B3">&nbsp;</td>
			<td id=".lead.B4">&nbsp;</td>
			<td id=".symb.B4">&nbsp;</td>
			<td id=".amt.B4">&nbsp;</td>
			<td id=".trail.B4">&nbsp;</td>
			<td id=".lead.B5">&nbsp;</td>
			<td id=".symb.B5">&nbsp;</td>
			<td id=".amt.B5">&nbsp;</td>
			<td id=".trail.B5">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: Times New Roman,Times,serif; font-size: 10pt;">
			<p style="font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Other income:</p>
			</td>
			<td id=".lead.B2" style="font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B2" style="font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B2" style="text-align: left; font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B2" style="font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.B3" style="font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B3" style="font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B3" style="text-align: left; font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B3" style="font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.B4" style="font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B4" style="font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B4" style="text-align: left; font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B4" style="font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.B5" style="font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B5" style="font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B5" style="text-align: left; font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B5" style="font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: Times New Roman,Times,serif; font-size: 10pt;">
			<p style="font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Interest income</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.2" style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">1</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.3" style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">1</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.4" style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">3</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".lead.5" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.5" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.5" style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">1</td>
			<td id=".trail.5" nowrap="true" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.2" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.2" style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">1</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.3" style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">1</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.4" style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">3</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.5" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.5" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.5" style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">1</td>
			<td id=".trail.5" nowrap="true" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td>&nbsp;</td>
			<td id=".lead.B2">&nbsp;</td>
			<td id=".symb.B2">&nbsp;</td>
			<td id=".amt.B2">&nbsp;</td>
			<td id=".trail.B2">&nbsp;</td>
			<td id=".lead.B3">&nbsp;</td>
			<td id=".symb.B3">&nbsp;</td>
			<td id=".amt.B3">&nbsp;</td>
			<td id=".trail.B3">&nbsp;</td>
			<td id=".lead.B4">&nbsp;</td>
			<td id=".symb.B4">&nbsp;</td>
			<td id=".amt.B4">&nbsp;</td>
			<td id=".trail.B4">&nbsp;</td>
			<td id=".lead.B5">&nbsp;</td>
			<td id=".symb.B5">&nbsp;</td>
			<td id=".amt.B5">&nbsp;</td>
			<td id=".trail.B5">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: Times New Roman,Times,serif; font-size: 10pt;">
			<p style="font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Net loss</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
			<td id=".amt.2" style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(589</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">)</td>
			<td id=".lead.3" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
			<td id=".amt.3" style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(464</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">)</td>
			<td id=".lead.4" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
			<td id=".amt.4" style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(1,654</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">)</td>
			<td id=".lead.5" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.5" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
			<td id=".amt.5" style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(2,336</td>
			<td id=".trail.5" nowrap="true" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td>&nbsp;</td>
			<td id=".lead.B2">&nbsp;</td>
			<td id=".symb.B2">&nbsp;</td>
			<td id=".amt.B2">&nbsp;</td>
			<td id=".trail.B2">&nbsp;</td>
			<td id=".lead.B3">&nbsp;</td>
			<td id=".symb.B3">&nbsp;</td>
			<td id=".amt.B3">&nbsp;</td>
			<td id=".trail.B3">&nbsp;</td>
			<td id=".lead.B4">&nbsp;</td>
			<td id=".symb.B4">&nbsp;</td>
			<td id=".amt.B4">&nbsp;</td>
			<td id=".trail.B4">&nbsp;</td>
			<td id=".lead.B5">&nbsp;</td>
			<td id=".symb.B5">&nbsp;</td>
			<td id=".amt.B5">&nbsp;</td>
			<td id=".trail.B5">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: Times New Roman,Times,serif; font-size: 10pt;">
			<p style="font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Loss<font style="font-family:Times New Roman, Times, serif;font-size:10pt;"> per common share</font></p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
			<td id=".amt.2" style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(0.01</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">)</td>
			<td id=".lead.3" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
			<td id=".amt.3" style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(0.01</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">)</td>
			<td id=".lead.4" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
			<td id=".amt.4" style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(0.03</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">)</td>
			<td id=".lead.5" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.5" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
			<td id=".amt.5" style="width: 9%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(0.06</td>
			<td id=".trail.5" nowrap="true" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td>
		</tr>

</table>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" id="TBL2" style="width:100%;text-indent:0;font-family:Times New Roman, Times, serif;font-size:10pt;">

		<tr>
			<td colspan="1" style="vertical-align:top;width:100%;">
			<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>GEOVAX LABS, INC.</b></p>
			</td>
		</tr>
		<tr>
			<td colspan="1" style="vertical-align:top;width:100%;">
			<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>Condensed </b><font style="font-family:Times New Roman, Times, serif;font-size:10pt;"><b>Consolidated </b><b>Balance Sheet Information</b></font></p>
			</td>
		</tr>
		<tr>
			<td colspan="1" style="vertical-align:top;width:100%;">
			<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>(amounts in thousands)</b></p>
			</td>
		</tr>

</table>

<p style="margin: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman,Times,serif; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.D3" style="font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td colspan="2" id=".amt.D3" style="text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;">Sep<font style="font-family:Times New Roman, Times, serif;font-size:10pt;"> 30,</font></p>
			</td>
			<td id=".trail.D3" style="font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.D4" style="font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td colspan="2" id=".amt.D4" style="text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;">Dec. 31,</p>
			</td>
			<td id=".trail.D4" style="font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.D3" style="font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td colspan="2" id=".amt.D3" style="text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;">201<font style="font-family:Times New Roman, Times, serif;font-size:10pt;">7</font></p>
			</td>
			<td id=".trail.D3" style="font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".lead.D4" style="font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td colspan="2" id=".amt.D4" style="text-align: center; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;">20<font style="font-family:Times New Roman, Times, serif;font-size:10pt;">16</font></p>
			</td>
			<td id=".trail.D4" style="font-family: Times New Roman,Times,serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td colspan="1" style="text-align: left; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family: Times New Roman,Times,serif; font-size: 10pt; margin: 0pt; text-align: left;">Assets:</p>
			</td>
			<td id=".lead.B3" style="font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B3" style="font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B3" style="text-align: left; font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B3" style="font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.B4" style="font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B4" style="font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B4" style="text-align: left; font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B4" style="font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: Times New Roman,Times,serif; font-size: 10pt; width: 67.4%;">
			<p style="font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Cash and cash equivalents</p>
			</td>
			<td id=".lead.3" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">344</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.4" style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">454</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: Times New Roman,Times,serif; font-size: 10pt;">
			<p style="font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Other current assets</p>
			</td>
			<td id=".lead.3" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">102</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.4" style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">90</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: Times New Roman,Times,serif; font-size: 10pt;">
			<p style="font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Total current assets</p>
			</td>
			<td id=".lead.3" style="width: 1%; border-bottom: 1px none rgb(0, 0, 0); font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; border-bottom: 1px none rgb(0, 0, 0); font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; border-bottom: 1px none rgb(0, 0, 0); text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">446</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; border-bottom: 1px none rgb(0, 0, 0); font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; border-bottom: 1px none rgb(0, 0, 0); font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; border-bottom: 1px none rgb(0, 0, 0); font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.4" style="width: 12%; border-bottom: 1px none rgb(0, 0, 0); text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">544</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; border-bottom: 1px none rgb(0, 0, 0); font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td>&nbsp;</td>
			<td id=".lead.B3">&nbsp;</td>
			<td id=".symb.B3">&nbsp;</td>
			<td id=".amt.B3">&nbsp;</td>
			<td id=".trail.B3">&nbsp;</td>
			<td id=".lead.B4">&nbsp;</td>
			<td id=".symb.B4">&nbsp;</td>
			<td id=".amt.B4">&nbsp;</td>
			<td id=".trail.B4">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: Times New Roman,Times,serif; font-size: 10pt;">
			<p style="font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Property, net</p>
			</td>
			<td id=".lead.3" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">39</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.4" style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">55</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: Times New Roman,Times,serif; font-size: 10pt;">
			<p style="font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Other assets</p>
			</td>
			<td id=".lead.3" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">11</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.4" style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">11</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: Times New Roman,Times,serif; font-size: 10pt;">
			<p style="font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Total assets</p>
			</td>
			<td id=".lead.3" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; padding-bottom: 3px;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">496</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
			<td id=".amt.4" style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">610</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td>&nbsp;</td>
			<td id=".lead.B3">&nbsp;</td>
			<td id=".symb.B3">&nbsp;</td>
			<td id=".amt.B3">&nbsp;</td>
			<td id=".trail.B3">&nbsp;</td>
			<td id=".lead.B4">&nbsp;</td>
			<td id=".symb.B4">&nbsp;</td>
			<td id=".amt.B4">&nbsp;</td>
			<td id=".trail.B4">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td colspan="1" style="text-align: left; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family: Times New Roman,Times,serif; font-size: 10pt; margin: 0pt; text-align: left;">Liabilities and stockholders<font style="font-family:Times New Roman, Times, serif;font-size:10pt;">&rsquo; equity</font></p>
			</td>
			<td id=".lead.B3" style="font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B3" style="font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B3" style="text-align: left; font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B3" style="font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.B4" style="font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B4" style="font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B4" style="text-align: left; font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B4" style="font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: Times New Roman,Times,serif; font-size: 10pt;">
			<p style="font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Current liabilities</p>
			</td>
			<td id=".lead.3" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">732</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.4" style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">370</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: Times New Roman,Times,serif; font-size: 10pt;">
			<p style="font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Stockholders<font style="font-family:Times New Roman, Times, serif;font-size:10pt;">&rsquo; equity</font></p>
			</td>
			<td id=".lead.3" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(236</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">)</td>
			<td id=".lead.4" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.4" style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">240</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: Times New Roman,Times,serif; font-size: 10pt;">
			<p style="font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Total liabilities and stockholders<font style="font-family:Times New Roman, Times, serif;font-size:10pt;">&rsquo; equity</font></p>
			</td>
			<td id=".lead.3" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">496</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0); margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
			<td id=".amt.4" style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">610</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td>&nbsp;</td>
			<td id=".lead.B3">&nbsp;</td>
			<td id=".symb.B3">&nbsp;</td>
			<td id=".amt.B3">&nbsp;</td>
			<td id=".trail.B3">&nbsp;</td>
			<td id=".lead.B4">&nbsp;</td>
			<td id=".symb.B4">&nbsp;</td>
			<td id=".amt.B4">&nbsp;</td>
			<td id=".trail.B4">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: Times New Roman,Times,serif; font-size: 10pt;">
			<p style="font-family: Times New Roman,Times,serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Common shares o<font style="font-family:Times New Roman, Times, serif;font-size:10pt;">utstanding</font></p>
			</td>
			<td id=".lead.3" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">70,914</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.4" style="width: 12%; text-align: right; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">55,235</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: Times New Roman,Times,serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>

</table>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<p style="font-family: Times New Roman,Times,serif; font-size: 10pt; margin: 0pt; text-align: center;">###</p>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>geologo.jpg
<TEXT>
begin 644 geologo.jpg
M_]C_X  02D9)1@ ! @$ 2 !(  #_[@ A061O8F4 9$     ! P 0 P(#!@
M             /_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$! 0$!
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\( $0@ -0#' P$1  (1 0,1 ?_$ /$   (# 0$  P$!
M      D*  <(!@4"! L! P$  @,! 0$!            !08 ! <# @@!$
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MZS]-M_(7XKEZL]?BO[W]K/-YB7RS^&C]?>[I7R3Z(_K>N%[][5X%O-TU_]H
M" $#  $% /J&/D2_!74WP>"/EOV<OD%'MY=(Q"G/D4OSY$#Y\A@<I(A#ED@H
ME>$W@B'AP12[@<X!LF-3^!0<*.F<.2&%3@CO<JA?:@O!5X7CH>ZH+ 1[.!,]
MNA<#0D4+EA$D'R@0=O/+3GEMKRH(-W+T\@)QU!I:.FMQL$S+?&CU*NKTDX27
M*G'ZF<+/\"V\@LI:G3P6EXBA@JKK5U2J2@*2S<FL1+*T +%RMCA=UY,Q8B/=
M0ITL[J<;X"F63_H>Q8V$50E&BJE<<5]SA=%EEH=GB:)%#MBBPT\;EJPYFL(6
M74\XFJA\93/M=$M6U ((( /BX>N34EAI0="X@P07/S"G*"!UL/OTD ,G/P@9
M&O%###.2 5L&(NU*7:,PP*F*JH>L34]JC%DT"^0KZW72"#6]P+JBAT35 NJ$
MZ.P<ZL6^;RC@ F0A$VK?<CK;8Z::8ZJ 04?!U 7F6^Q388Z(N-.JZH'F" 3)
M%SHQ5EMM+))"0YEILK)(ZK&16>B)!5()/A'*BIR@(9#+O15_/",)MAEQ@@ %
MPGJE%D]1,%@39<_<HM8RU40)(3^776V6W%Z*2I=;2ZBLQDX[4F;<[?H06DQ3
MY6E+J'D]39ZB6?Z.*&I/-#-)Z&DWK#43'2 $FVF([MHI$$QP-Y&?!0,JO.$1
MRW#( =S;9"8(;57:1.IZF _46\!>6Q5T\N+ *(01FP,O%6VOW(0P)VPS00$,
M6OFM^_BJ>P\*_:M;:#TM.]"^M_7G$+I_[+73'G_KSB%TYYUCI+UD;V'TN)_M
MOWN\OE,]!_DJ/2OX![H[SA>GZ=_M?YW@-]O>?__:  @! 0 !!0#Z:UI2C^R@
MQJBJCPW6:L60*Z>Y)U<MZ]Q=TU@.F44^[+QC!ON[LB+QJV=UJU!*A=UK'ME4
M_NO<8_,W^ZAUVJ7("WY:Y<C9(8+[BS:+N.C>;\?I (_P90[5<!\0!)[[J]I$
M[W7O<V]93N%&UD[[,U:Q7VGDE* L>]KG@6W0&;H4U2,T%HZT=>K%M1<<<>6W
M0FSF@G6V$"%E!$U.&H>83%5+5O%K&1S4W5M7#3 +$+4OIK@:9-6S_P"U;PF5
M+[]&&U#'BHL_=SCA[R)>Z%C)*7<9MA.%^80'AL'V8XW:Y6!FYNZSIS3-8-:Q
M,M]@"UB7VT&&4/ 1C#T3PJW-JN]U=@F4D#7/W&.413]*^]T+FK2.<R(>Q<^C
MN*(?G-E0KK4RV*9MX5<VM+BQM-W-H*$CM=#\9CQ[@K(5O96]LCBY((J5GIN&
MTLN^'-E>+,^XBYA9,/W,+);3'KI3-B>4S'8S-C-H<V0Y'*N)6#/;)84M<&+G
M.^62R;/GF#>%70VCS?R?[GC'F.7_ (H=S5C5+L@.-XM-GM.>>Z0AEOOO'/>C
MA9LI3.WTE!XX=9J9G9*-W$#%G28^8?Q$C-;[JARGU=7[IM@BKFT;9/EIK;IB
M3E5$V9\ EMX\CY YYI'NU$N2(U8$P,9V8@&]7.W/=MJ3DC#^8NV_S3CS&?*S
MPW9QBO2SJX[:6;6O(NN;9'HW.[+\I,D^U]C.!,>8KR)?<0=OCJ0PPQYP.P6W
M!;!]/>?V/61N<LPNS0GKHP/A7!+'7N0\#8:>F)V4KEE]JQAW"N:MF43.E3$5
M&ES;*PXRCN+F/W#N$41XKY:2U$L>SO%V32CE7I>EO2=KF9.".*W%=724!+4H
MJ(9>9HJ">05B&;_;88I9 &8$G3<EJX(8M;&,-LQK#I(FI$LEL6LQ]!^6<0]T
M)@2\&MESW ^N&:,5M;^$3@STTC8;;J(T9>(:?*_:DIY#+O&/#_9_JIU]=Q]"
MC1AK9CM1=>WY3D35ZUEO4=VY>(#@G+-O>?CAD%BMF/'/<Y:\W)'&S78D\=E&
M3&R?/V/==F,^OW37(&SB%M2&SM9UM/Y@9%(<R%7/'C7?!B]330S_ (YJ_J^]
M.'PBHQQ+"DTDE9$5[:FK\_\ *3S6A^K+T]AOZ:O??_*3S6E^IGWS/K]%_P A
MZ_OUF]'<Q;_R+^4I>W>W2S_S'_*^5?Z1_P#,.2?_ #]]3L[I/I%Q_P"*?]+^
M$@T)?L(__]H " $" @8_ /TAW33,Q5GZM-V^8&P*:#6 /UL*?RV6W;RU"G]Z
MJG\TM;\S.Y-?>=OFIV[>L9<=2U#_ #1;MZ_1'^&WTL+7^)*/_;/].W9\14#[
MC?TC;\K6,LWNU!_--OR\SE''WW'ST[9G.YG+T3EJ2%F*U4, =!().X "22 !
M)MD](TG+NWB+-+$4U)J8V7'6<81B_*I]@-[)PD69L[DJ]-B;RZ,IGIQ ?\%7
MR&EU#0/]8_83KQ- /NR;*^KZPJ<5HJ6/XWPCS*;"OGZ6-1[>8JX5\P--?GL5
MR29<U!NR] ,?QD*/+C-L.GZ+5<<:E0*/PH&_E6/=LIE:*_=9SYV8C]FQ_C+(
M.")37TA9]-CSM?S9_P 5Q\Q%OS=1KMUU'/SFW:K.>LFU[&US&W8KN.IB/IM^
M5JF97JJ./F:U')9_5,S6TBC%:JCU&96Y; TU(),S4P&. /"U9M'K(!E*1H2R
MJX+,0U:)!@E@$)$&$VP;8<YD,K63J=#Z&(_9L!KG@Y,9VLBTW/GPTV_:FQ&5
MU&ID:YW,S()_Q0Z>9Q8YC0M:H9J@=F+L^9U+H?*5L?B>F5:=/ZT8D/4ZROIG
MY6I9% N60CF56G D[N+,=RB\[X%]DJ]V&9SP_K*H#0?L)>J]![3?:M_$<S.:
M*RM)(:H1NNF%7I8@<)L]/2J:9/+[B(>J1TNP@>ZH(XV-?/9NI6K'VG8L?.2;
M+KOB*L:.DX<2K(0NH]MW-U.GP/K-M$""3E<GHB5PMQ9:"N#'VZS!FZ]G"U_A
M>_\ ^-E_Z5N^>'J'*R-6DA*8<&&I>'&$2!L!A3AOD;?T:WA_5LAEZU&NA-,U
M*:,P<"60,5Q0ZR8FYE$02;:AIL'DJ^*F>--NTGF!@](/R:AXES"@9S,*74'>
M!*4%ZF<E_ND'=:I5JL6J,Q))VDDR2>L_H"MIV>JT*G%&*SUP;_+84-;RU/.9
M4W$P$J1TP,#]3+?O-JN:\/5QE-5 ED PP?MT9B)VO2,<9V6RFA9VB$S5>JB4
MVG\M\;!%8,!>LF^[$NP@&ZV2TS*J E-!B(]IR.VYXEFOZ! %P%A5RL'4J[%*
M4WA8$M4(.W"" !LQ,)D BU7,YFLU3,.TLS$DDG>2=OR:3IM7]S4JC']Q99QY
M54BV7\-Y5L&2I4U>HJW!F(E%('LTT@J-DF=PAA0H.Y&W"I,=< V_]"M^!OU6
MY+4F%:8PP9D[!&V>BRYK6,^F34B<&'&X!^OVE5#T8B1O -UGS>DYU,Y3425"
MX'('U!+*_4&Q'<";4\O1I,U=F"A0"6+$P !MDFZ++F-8U:GE6(]0+C*SN9L2
M(#Q +==J.O:3FES5/+,*DJ"KJ%,XBDG$MW:*L;ID1)MHOC#(+V,"J_0E2]9_
MNZF)#TM;3]*I;:U0 G@NUV]U03Y+:1X)\/T)6E3%6I?"4T P4L;; %63%Y.)
M8!,66GFO$BKG&%RBF(\F*HK,.D*.JV>6OJ@6O3$TV"S3J""8:6#TV!$,(87@
M@M>!4RAUFKE]552<!IJRL!M9&QJ3A]I2 0+Q(F,SIF>2*],W$;&4^JZG>K"\
M>8P019->\2:L^6=@"**TPSDM>B=IU_,87D1""<1N-FY<\N;IVQTQ=-J6;R==
MJ>9IF593!!Z#_P R+C=;,ZO51$U[2FYP:! JT0*JN!]6JJE679B&R MLKI6=
MK!-:HH$@F.<JB RD[7@=M=I(Q"03&6S^3IEZV39F91M--P,1 WE"H)'U9.[Y
M=$JUF IM4*2>-160?M,+-G&4\G,T493NE%%-AU@J">AAQL-/RVE"MF'K,[N7
M*7$*%6X$F "9)@3 &VVGZ>VBHBUZZ4RPJL2,;!9 *WQ,QOMIU>M34M0TWF[-
MKBJU-">)7%(X%1P%LUD5=SE:=<TJ-(&Z5; #&PNYO)-]\"X"U YA$&CU+JJ<
MU6PR+F50QAU,>KM$K>#;7=06F!@RU.JH@0M2O(=@./9<C@7MF<SFJS=W#D4Z
M<G"B F !LF/6;:QDFU+0:M9GT^NKX5)D(ZJ6!6=@8*58"XR#M%O&?@"K R@9
MJE$?5IUPK,%_NJC*R]9MX@UO5EP=T+T).[!VJ[#J4!0=^(BVO^-:=,?$\[6=
M@2 <(YG(H*>*TEO V$[=MGS>:S#U,RQDLQ)8GC)OMJ.3S]5JE;*0%=KV*.K0
MK$WDJ5,$WP0-ULOGLE6-/-4G#*PW$?.#L(-Q$@W&VA^(L[D(SF6<B"(7&NU;
MQVZ6(AT$W&5-^,&K2 =-/RS,E-&!!D&'=P;P[$;#>J@+M!FRTZ:%JC&  )))
MV  7DFV9\,9)Q4UK4:J"OA(*TE!A* :8-1B3S"#A0' 3BQ85=&(<&01<01L(
M/&U/+ZM3[YE1=B)PU0/OWA_?!)^M9LWH>JIIVKO>:5<<ND['@1*H2=Z,0?J"
M9MBU#3W&7.RHO;I-TBHLK?P)!Z+*RL0P,@C:#QM2T37J@IZY3V&0&9@(YM(F
MXEA^\I[S>!$%67)5\O7HS<<7+;RJPN/4S==M*SV8HT.11S%-VBJI.%7!, ;3
M N&^VB9[,3W-\ERZA DA'J/V@-^%@K1O (%]LOXK\*U:%:G4JK7Y98!2X(;$
MC^JR.UY!(()(%VQF[^HDS ?+P.H1LLS^,W8'/4@K5&8,  ?RW!65PHRE6 C"
M"3%U]7/^'*E*ID:Y+A"X4KBO[+'LNE_9(,@0(,2<SXF\39RDM6G3(4*9"8A!
MONQU&'955G:;S-Q\4,I%-\P2R_\ 1;L%>DBG^T ;4].RCCG:@TDK=-(0S-=M
MYAP"=XQ6SW@?5J@0U,7*,@8@T,0I-W,1QC4>U)$&#+4LLV7JY:;JF,)=]I6[
M0/$ -T$VKY$5Q4S]08ZK"Z_"0H4&\(+PI/K'$;M@I9&C*Y9>U5J1<B;SPQ'8
M@WGH!(TOP_H>70Y3*0*Z_9B.4IW. <;MMYA /M@Y7Q9X505JM90:B+ +C9C@
MD 5$C#44WF)V@RR9ZO32L/85EJ//2$)5>IF!Z+.*#86:XL+FCA.T [XB=AD6
M+X3@!V[O/^@?]O\ ?.5[7+Q<OIQ_U<<<=W&Q.MKI9S.\(8JSTG)@TI^^)XV'
M=UJH\W7A^J#"'JNFR_#_ (AW;V<?#HYM\=5UO]7_ )-LG_NS'CAN7CY>*+L4
M8>UAGCV9Z;/_ +8[YW:;\$\J?>_+GCOM_J_\FV3_ -V<R);E\SEXMV+#A[4;
M)]F8WV__ #G?>X[H_=^[C['7ALG^Z.]\SV>;BP].#V.O#Y?DTOXSS</=4Y&/
M^POP8?L[8W\=UEP3CFZ-L[HZ;)W7XCW:+L7K1T8^WU1;/_"N^_&,(YTSBB>S
MCYEVWU9OVX=]LS\$Q\GF-S.1W?\ >;\6#VN&_A:MWG%WC&<6*<6*>UBF^9F9
MOG;:IR.]_!<9Q8<?)Q0)F.Q,1,]'RU",/+Y+W>R>RU\[ 0VU<)8U0L,$)C__
MV@ ( 0,"!C\ _2//SM)/O.H^<V(;5*9/V9;^2#;LUJC]5-OIBW8R^8;W5'SO
M;LZ?5/6R#Z3;LZ54/OK^HV_^GJ?C']&U^D5?Q#]0MV].K#RH?I%NW1S"^ZI^
M9[4<M1K5.<[ *"C7D](! Z23 MF,_GZJC2*!GMD!,(.&FM]W;;M$;[Q8#+9F
MDXW864_,?^"5S6=7FCV5[3>99CRQ8KI^G,W!JAPC\*R?2+&EE7PD^S2IR?.<
M;?-;%F6K!#_:U"/V02?V;8LWJ2+]Q"WI8K\UASJ]>H?O!1Z%GTV'\.#'[3.W
MSM%AR]*RX]Q3\XM^7DZ2]2*/HMV::CR"VP6O46[5)3Y!;MY*BW6BGZ+5,SE<
MC1IY^I--&555AC!#D0!L3%?Q(M374*;?GN*L E2  13V;>R2P!NEK3ELU7IM
MUJW\T'TV_AGB)L/!BZ_2Z^BWY^33,TAO #']@JWG6PHZIIM6A5WQ?^R0K#S&
MW_A9U';ZLPWX3#>CY14S+%JS>J@]9OU#BQNZS=9DYW)RI]A"1=]IKF;IV#HM
M_P"'1BA-]1KD'&_:QZ%!/&+*^>9LQ6X'LI^$&3[Q/584\M02G3X* !Z+'2](
MIBIGY@M&(*WU54>L_'<-ADR!SLQJ34B;X-5E-_V:8@=5H&MW?WU7]5N[ZM5Q
MYI'8!IQ2MQ4XC>=L7WW0=GZ-/5LAFJU.I28!PCL 5-P8@&)5HW7@F=@ME,Y/
MYC+#]#K<WI$CH(^3*:-2:<O2.%HXGM53Y% 7K%EIHL(H  X 7 ?H&GF\LE1.
M#*#YIV>2QJZ;6;+UQ>!)99Z).)>L-Y+)0U>D<QD9@,3/X:FV?LU!/"-MJ^J9
M>H6H4D9G7VUPJ6*E>,"Z^#N,6S.=K,2SL8'U5]E1T >F3M-BE<GN=(!GC:9,
M*L[L5\G@#%Y!LE&C3"4E$  0 . 'R9_.I^\2F</WCV5])%JNLUQBS-1F52;X
M ]9ATLT@G; Z38&K550=DD#Y[?\ M4_Q+^NW,#@TXF9NCC.RS4-/RC9@CVIP
MJ?NW,6'3 '"19<OGLLV7<F,1.)9^T8!7K(CB19JU2H%I*)))N %\SPBS4M/R
M#UP/:)P@]($,T=) ZK5=+S]!J#U@4AB"K2(C% AN (%^PS;4O#V:;M8B5Z62
MXQ]](;J%LWGJFRFA('$[%'E,"VH>)=6JWNQ1-[.Q.)\(WDF!P$&2!8O0T9CE
MQM)<SY80J/.;94TLB328PX+0R7B\7%6!F1>#<00+C9*XTY*N18QB#D%3P883
M$[C,3<8NFCG<JTTW&S>IWJ>!!V^?819M*T?(+64&#49RJW>LURGL@W [6.S:
M+#'&*+XV6J4,Q25Z+""")!%J.0ILS:7GARR),E*G8*D\4)!#;8ZS:MGLM3+:
M=48M=_5DF2&X+/JG9N.Z:V5S#!:>8  )V!U)P@G=BD@=,#?\NI4Z8EP@;\#!
MCZ ;+EP1S:-1@1T,2RGRS'D-CFZV?-.DM-550N+>2QO( F1LVQ?NMF\V-29C
M2ILT8 )P@F)G?%LW2IN0*N<Y?4I0.P'"8@\9-J&9*J*STA4J5#MO&(B=RJ+H
M'"=IM5%%F.H)?3;EL)O]4D@2K#CLN-M+RA<]JLZ$SM2E>JGHO7R+:C1H4QS2
MH+O[3-%Y)VQ.P; +5-42F%S=(K)%V)2P4@QM()!!VB(WV\.>*TOKD!:AXO3)
M4$_WB*5/5;2=,R)Q=X"U(&_%=3'E))/4+:5X;=CW++4E! NDX.;4;K<W3MBR
MT*%)4HJ("@ ".JV3S&5IA*=>25%P#*1) W8@PD;)$[[5<MF*8:@ZP0=X/_-Q
MW&^VIZ1ELW.6K*+P;\)V'[+Q*MQ%X]DA'E6S=90SL+Q$2JJ=Z@':-I).R/D9
MW8!0))-P XFU'6LRN#3LHC<J09=C>U2-H0 #!=+$8MD258 J1!!WV>MD'[O7
M-\ 33)^[[/ND#HLN7U/(MG-/6X5*9Q.HZ1<S ?: /VC;#E,VIK#:A[+CK4P?
M1'38JPD&SZEI:%],?:+R "9P/%X /J/NW[P5;,4ZM*IO&'&/(5V^4"V>RU*I
M5YM2BZB48"2I D[K[:EE:4=X7,XTX%E1;O>!(Z)FU70M=IU:;K3-+$%DA8*P
MR[0RBX&"# \H'=28XK6GY[*OAQ01EJA*H 5-X[2PU^)@<0)VD 3:GE=72HF9
MIC"6"DAHNO'K*W$1$WW;+4=%T7+NR.P))$%HV7>R@/:9FX"X;_@:D%EI0I_Z
M@[0;HE_08L^;S"G!E!$'<YD!?=&(]!BV5\39!,02,>^"MP+1?A93A8[KN-A4
MK"JE:+UPXK^AA<1TF.D"U+-<HIE4.% >L%B3LQ&Z0-@@=)?-5(-8W(N]F_4-
MK'<.DBV>U;4ZS#,9B33/3_:$?5NPJOU9CV3:MH.NMRTIDA&,G"?JW;4;UD.R
M^-A$!LM2=J9]HJ47R8@"?(".FR\U<0&X[)XQOZ)V;K!<0Q</T!\5[OCW8L./
MW?;G[M]OX:<Z*.[$)3R#,$/'W3;\THRQ?<5\][#Z+-WONG/WX>/3@N\]O]/_
M )ELQ\!PX9&/#CPSNF;ICRQT67XUW?G;L48X\G:CT6_T_P#F6S'P'!,#'@QQ
MT3-T[8WQT6_B_=N\]/K^7#VO/9O@G(P;^7$^][7G^3._#L$\]N;A_M;L4].S
MHL<488OG9%FY_=.?-\;)Z</9ME>_]V^'R>7$89B_#@Z/6CRVH_$L./ ,/,YO
MJ[HQ;O1QM3Y,<K",,;(BZ(NB-D;K)S>1\2PB)P\S#-T3VHF8^5 <6/F+?O\
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MUX_Z7_\ GGQE7_++])>4]S7_ '8]MO=GTAYOVSKT_P";^L?Z5]3^7]3DZ/\
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KG",F8B1; T33N59,C$)P3<YI"1B'=;34(E(A(M8EM3E7IW+%>12;IK?_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
